Selected research
Industry Research
Safety Arteriovenous Fistula (AVF) Needle Industry Research Report 2026
Market perspective
The global Safety Arteriovenous Fistula (AVF) Needle market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Safety Arteriovenous Fistula (AVF) Needle is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Safety Arteriovenous Fistula (AVF) Needle is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Safety Arteriovenous Fistula (AVF) Needle is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Safety Arteriovenous Fistula (AVF) Needle include B. Braun, Fresenius, Nipro, JMS, Kawasumi Lab, NxStage Medical, Asahi Kasei, Beldico and Farmasol, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Safety Arteriovenous Fistula (AVF) Needle market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Safety Arteriovenous Fistula (AVF) Needle Market by Company
B. Braun
Fresenius
Nipro
JMS
Kawasumi Lab
NxStage Medical
Asahi Kasei
Beldico
Farmasol
Hemoclean
Bain Medical
Tiankang Medical
Hongda Medical
Baihe Medical
Dalian Aohua Medical Polymer Equipment
Sansin Medical
Zhejiang Kindly Medical Devices
Ningbo Tianyi Medical Appliance
Safety Arteriovenous Fistula (AVF) Needle Segment by Type
15G
16G
17G
18G
Others
Safety Arteriovenous Fistula (AVF) Needle Segment by Application
Hospital
Clinic
Dialysis Center
Safety Arteriovenous Fistula (AVF) Needle Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Safety Arteriovenous Fistula (AVF) Needle market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Safety Arteriovenous Fistula (AVF) Needle and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Safety Arteriovenous Fistula (AVF) Needle.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Safety Arteriovenous Fistula (AVF) Needle manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Safety Arteriovenous Fistula (AVF) Needle by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Safety Arteriovenous Fistula (AVF) Needle in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 15G
- 16G
- 17G
- 18G
- Others
Applications
- Hospital
- Clinic
- Dialysis Center
Companies covered
- B. Braun
- Fresenius
- Nipro
- JMS
- Kawasumi Lab
- NxStage Medical
- Asahi Kasei
- Beldico
- Farmasol
- Hemoclean
- Bain Medical
- Tiankang Medical
- Hongda Medical
- Baihe Medical
- Dalian Aohua Medical Polymer Equipment
- Sansin Medical
- Zhejiang Kindly Medical Devices
- Ningbo Tianyi Medical Appliance
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Safety Arteriovenous Fistula (AVF) Needle Market Size (2021-2032)
- 2.2.2 Global Safety Arteriovenous Fistula (AVF) Needle Sales (2021-2032)
- 2.2.3 Global Safety Arteriovenous Fistula (AVF) Needle Market Average Price (2021-2032)
- 2.3 Safety Arteriovenous Fistula (AVF) Needle by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 15G
- 2.3.3 16G
- 2.3.4 17G
- 2.3.5 18G
- 2.3.6 Others
- 2.4 Safety Arteriovenous Fistula (AVF) Needle by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital
- 2.4.3 Clinic
- 2.4.4 Dialysis Center
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Safety Arteriovenous Fistula (AVF) Needle Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Safety Arteriovenous Fistula (AVF) Needle Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Safety Arteriovenous Fistula (AVF) Needle Revenue of Manufacturers (2021-2026)
- 3.4 Global Safety Arteriovenous Fistula (AVF) Needle Average Price by Manufacturers (2021-2026)
- 3.5 Global Safety Arteriovenous Fistula (AVF) Needle Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Safety Arteriovenous Fistula (AVF) Needle, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Safety Arteriovenous Fistula (AVF) Needle, Product Type & Application
- 3.8 Global Manufacturers of Safety Arteriovenous Fistula (AVF) Needle, Established Date
- 3.9 Global Safety Arteriovenous Fistula (AVF) Needle Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 B. Braun
- 4.1.1 B. Braun Company Information
- 4.1.2 B. Braun Business Overview
- 4.1.3 B. Braun Safety Arteriovenous Fistula (AVF) Needle Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 B. Braun Safety Arteriovenous Fistula (AVF) Needle Product Portfolio
- 4.1.5 B. Braun Recent Developments
- 4.2 Fresenius
- 4.2.1 Fresenius Company Information
- 4.2.2 Fresenius Business Overview
- 4.2.3 Fresenius Safety Arteriovenous Fistula (AVF) Needle Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Fresenius Safety Arteriovenous Fistula (AVF) Needle Product Portfolio
- 4.2.5 Fresenius Recent Developments
- 4.3 Nipro
- 4.3.1 Nipro Company Information
- 4.3.2 Nipro Business Overview
- 4.3.3 Nipro Safety Arteriovenous Fistula (AVF) Needle Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Nipro Safety Arteriovenous Fistula (AVF) Needle Product Portfolio
- 4.3.5 Nipro Recent Developments
- 4.4 JMS
- 4.4.1 JMS Company Information
- 4.4.2 JMS Business Overview
- 4.4.3 JMS Safety Arteriovenous Fistula (AVF) Needle Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 JMS Safety Arteriovenous Fistula (AVF) Needle Product Portfolio
- 4.4.5 JMS Recent Developments
- 4.5 Kawasumi Lab
- 4.5.1 Kawasumi Lab Company Information
- 4.5.2 Kawasumi Lab Business Overview
- 4.5.3 Kawasumi Lab Safety Arteriovenous Fistula (AVF) Needle Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Kawasumi Lab Safety Arteriovenous Fistula (AVF) Needle Product Portfolio
- 4.5.5 Kawasumi Lab Recent Developments
- 4.6 NxStage Medical
- 4.6.1 NxStage Medical Company Information
- 4.6.2 NxStage Medical Business Overview
- 4.6.3 NxStage Medical Safety Arteriovenous Fistula (AVF) Needle Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 NxStage Medical Safety Arteriovenous Fistula (AVF) Needle Product Portfolio
- 4.6.5 NxStage Medical Recent Developments
- 4.7 Asahi Kasei
- 4.7.1 Asahi Kasei Company Information
- 4.7.2 Asahi Kasei Business Overview
- 4.7.3 Asahi Kasei Safety Arteriovenous Fistula (AVF) Needle Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Asahi Kasei Safety Arteriovenous Fistula (AVF) Needle Product Portfolio
- 4.7.5 Asahi Kasei Recent Developments
- 4.8 Beldico
- 4.8.1 Beldico Company Information
- 4.8.2 Beldico Business Overview
- 4.8.3 Beldico Safety Arteriovenous Fistula (AVF) Needle Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Beldico Safety Arteriovenous Fistula (AVF) Needle Product Portfolio
- 4.8.5 Beldico Recent Developments
- 4.9 Farmasol
- 4.9.1 Farmasol Company Information
- 4.9.2 Farmasol Business Overview
- 4.9.3 Farmasol Safety Arteriovenous Fistula (AVF) Needle Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Farmasol Safety Arteriovenous Fistula (AVF) Needle Product Portfolio
- 4.9.5 Farmasol Recent Developments
- 4.10 Hemoclean
- 4.10.1 Hemoclean Company Information
- 4.10.2 Hemoclean Business Overview
- 4.10.3 Hemoclean Safety Arteriovenous Fistula (AVF) Needle Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Hemoclean Safety Arteriovenous Fistula (AVF) Needle Product Portfolio
- 4.10.5 Hemoclean Recent Developments
- 4.11 Bain Medical
- 4.11.1 Bain Medical Company Information
- 4.11.2 Bain Medical Business Overview
- 4.11.3 Bain Medical Safety Arteriovenous Fistula (AVF) Needle Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Bain Medical Safety Arteriovenous Fistula (AVF) Needle Product Portfolio
- 4.11.5 Bain Medical Recent Developments
- 4.12 Tiankang Medical
- 4.12.1 Tiankang Medical Company Information
- 4.12.2 Tiankang Medical Business Overview
- 4.12.3 Tiankang Medical Safety Arteriovenous Fistula (AVF) Needle Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Tiankang Medical Safety Arteriovenous Fistula (AVF) Needle Product Portfolio
- 4.12.5 Tiankang Medical Recent Developments
- 4.13 Hongda Medical
- 4.13.1 Hongda Medical Company Information
- 4.13.2 Hongda Medical Business Overview
- 4.13.3 Hongda Medical Safety Arteriovenous Fistula (AVF) Needle Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Hongda Medical Safety Arteriovenous Fistula (AVF) Needle Product Portfolio
- 4.13.5 Hongda Medical Recent Developments
- 4.14 Baihe Medical
- 4.14.1 Baihe Medical Company Information
- 4.14.2 Baihe Medical Business Overview
- 4.14.3 Baihe Medical Safety Arteriovenous Fistula (AVF) Needle Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Baihe Medical Safety Arteriovenous Fistula (AVF) Needle Product Portfolio
- 4.14.5 Baihe Medical Recent Developments
- 4.15 Dalian Aohua Medical Polymer Equipment
- 4.15.1 Dalian Aohua Medical Polymer Equipment Company Information
- 4.15.2 Dalian Aohua Medical Polymer Equipment Business Overview
- 4.15.3 Dalian Aohua Medical Polymer Equipment Safety Arteriovenous Fistula (AVF) Needle Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Dalian Aohua Medical Polymer Equipment Safety Arteriovenous Fistula (AVF) Needle Product Portfolio
- 4.15.5 Dalian Aohua Medical Polymer Equipment Recent Developments
- 4.16 Sansin Medical
- 4.16.1 Sansin Medical Company Information
- 4.16.2 Sansin Medical Business Overview
- 4.16.3 Sansin Medical Safety Arteriovenous Fistula (AVF) Needle Sales, Revenue and Gross Margin (2021-2026)
- 4.16.4 Sansin Medical Safety Arteriovenous Fistula (AVF) Needle Product Portfolio
- 4.16.5 Sansin Medical Recent Developments
- 4.17 Zhejiang Kindly Medical Devices
- 4.17.1 Zhejiang Kindly Medical Devices Company Information
- 4.17.2 Zhejiang Kindly Medical Devices Business Overview
- 4.17.3 Zhejiang Kindly Medical Devices Safety Arteriovenous Fistula (AVF) Needle Sales, Revenue and Gross Margin (2021-2026)
- 4.17.4 Zhejiang Kindly Medical Devices Safety Arteriovenous Fistula (AVF) Needle Product Portfolio
- 4.17.5 Zhejiang Kindly Medical Devices Recent Developments
- 4.18 Ningbo Tianyi Medical Appliance
- 4.18.1 Ningbo Tianyi Medical Appliance Company Information
- 4.18.2 Ningbo Tianyi Medical Appliance Business Overview
- 4.18.3 Ningbo Tianyi Medical Appliance Safety Arteriovenous Fistula (AVF) Needle Sales, Revenue and Gross Margin (2021-2026)
- 4.18.4 Ningbo Tianyi Medical Appliance Safety Arteriovenous Fistula (AVF) Needle Product Portfolio
- 4.18.5 Ningbo Tianyi Medical Appliance Recent Developments
5 Global Safety Arteriovenous Fistula (AVF) Needle Market Scenario by Region
- 5.1 Global Safety Arteriovenous Fistula (AVF) Needle Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Safety Arteriovenous Fistula (AVF) Needle Sales by Region: 2021-2032
- 5.2.1 Global Safety Arteriovenous Fistula (AVF) Needle Sales by Region: 2021-2026
- 5.2.2 Global Safety Arteriovenous Fistula (AVF) Needle Sales by Region: 2027-2032
- 5.3 Global Safety Arteriovenous Fistula (AVF) Needle Revenue by Region: 2021-2032
- 5.3.1 Global Safety Arteriovenous Fistula (AVF) Needle Revenue by Region: 2021-2026
- 5.3.2 Global Safety Arteriovenous Fistula (AVF) Needle Revenue by Region: 2027-2032
- 5.4 North America Safety Arteriovenous Fistula (AVF) Needle Market Facts & Figures by Country
- 5.4.1 North America Safety Arteriovenous Fistula (AVF) Needle Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Safety Arteriovenous Fistula (AVF) Needle Sales by Country (2021-2032)
- 5.4.3 North America Safety Arteriovenous Fistula (AVF) Needle Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Safety Arteriovenous Fistula (AVF) Needle Market Facts & Figures by Country
- 5.5.1 Europe Safety Arteriovenous Fistula (AVF) Needle Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Safety Arteriovenous Fistula (AVF) Needle Sales by Country (2021-2032)
- 5.5.3 Europe Safety Arteriovenous Fistula (AVF) Needle Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Safety Arteriovenous Fistula (AVF) Needle Market Facts & Figures by Country
- 5.6.1 Asia Pacific Safety Arteriovenous Fistula (AVF) Needle Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Safety Arteriovenous Fistula (AVF) Needle Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Safety Arteriovenous Fistula (AVF) Needle Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Safety Arteriovenous Fistula (AVF) Needle Market Facts & Figures by Country
- 5.7.1 South America Safety Arteriovenous Fistula (AVF) Needle Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Safety Arteriovenous Fistula (AVF) Needle Sales by Country (2021-2032)
- 5.7.3 South America Safety Arteriovenous Fistula (AVF) Needle Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.7.7 Colombia
- 5.8 Middle East and Africa Safety Arteriovenous Fistula (AVF) Needle Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Safety Arteriovenous Fistula (AVF) Needle Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Safety Arteriovenous Fistula (AVF) Needle Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Safety Arteriovenous Fistula (AVF) Needle Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Safety Arteriovenous Fistula (AVF) Needle Sales by Type (2021-2032)
- 6.1.1 Global Safety Arteriovenous Fistula (AVF) Needle Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Safety Arteriovenous Fistula (AVF) Needle Sales Market Share by Type (2021-2032)
- 6.2 Global Safety Arteriovenous Fistula (AVF) Needle Revenue by Type (2021-2032)
- 6.2.1 Global Safety Arteriovenous Fistula (AVF) Needle Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Safety Arteriovenous Fistula (AVF) Needle Revenue Market Share by Type (2021-2032)
- 6.3 Global Safety Arteriovenous Fistula (AVF) Needle Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Safety Arteriovenous Fistula (AVF) Needle Sales by Application (2021-2032)
- 7.1.1 Global Safety Arteriovenous Fistula (AVF) Needle Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Safety Arteriovenous Fistula (AVF) Needle Sales Market Share by Application (2021-2032)
- 7.2 Global Safety Arteriovenous Fistula (AVF) Needle Revenue by Application (2021-2032)
- 7.2.1 Global Safety Arteriovenous Fistula (AVF) Needle Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Safety Arteriovenous Fistula (AVF) Needle Revenue Market Share by Application (2021-2032)
- 7.3 Global Safety Arteriovenous Fistula (AVF) Needle Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Safety Arteriovenous Fistula (AVF) Needle Value Chain Analysis
- 8.1.1 Safety Arteriovenous Fistula (AVF) Needle Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Safety Arteriovenous Fistula (AVF) Needle Production Mode & Process
- 8.2 Safety Arteriovenous Fistula (AVF) Needle Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Safety Arteriovenous Fistula (AVF) Needle Distributors
- 8.2.3 Safety Arteriovenous Fistula (AVF) Needle Customers
9 Global Safety Arteriovenous Fistula (AVF) Needle Analyzing Market Dynamics
- 9.1 Safety Arteriovenous Fistula (AVF) Needle Industry Trends
- 9.2 Safety Arteriovenous Fistula (AVF) Needle Industry Drivers
- 9.3 Safety Arteriovenous Fistula (AVF) Needle Industry Opportunities and Challenges
- 9.4 Safety Arteriovenous Fistula (AVF) Needle Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst